Allergan Aktie

Allergan für 0 Euro bei ZERO ordern (zzgl. Spreads)

WKN DE: A14U12 / ISIN: IE00BY9D5467

<
Kurse + Charts + Realtime
Kurs + Chart
Times + Sales
Börsenplätze
>
<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs
>
05.02.2018 13:59:36

Allergan Names Matthew Walsh EVP & CFO - Quick Facts

(RTTNews) - Allergan plc (AGN) announced that Matthew Walsh has been appointed Executive Vice President and CFO. Walsh currently serves as the Executive Vice President and Chief Financial Officer at Catalent, a role he assumed in 2008. Prior to joining Catalent, Walsh was President, Chief Financial Officer and Acting Chief Executive Officer at Escala Group, Inc.

"Matt Walsh is an experienced Chief Financial Officer with a strong track record of creating value for shareholders, including 14 years as a CFO with three public companies and ten years in health care as CFO at Catalent where he led their transformation under private equity, a successful IPO and numerous acquisition and divestiture transactions, all while driving sustained organic growth," said Brent Saunders, CEO.

Nachrichten zu Allergan plcmehr Nachrichten

Keine Nachrichten verfügbar.

Analysen zu Allergan plcmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!